Skip to main content

Table 1 Demographic and clinical data

From: Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?

Patient

Age (years)

Gender

Duration

Branch

Trigger points

1

72

M

7

Right V2

Infra orbital

2

35

F

5

Left V1

Eye brow

3

44

M

4.5

Left V2 & 3

Infra orbital & upper lip & mentalis

4

50

M

7

Right V1 & 2

Eye brow & infra orbital

5

52

F

9

Right V3

Mentalis

6

45

F

6

Right V2 & 3

Infra orbital & upper lip & mentalis

7

46

F

5.5

Left V2 & 3

Nostril & upper lip

8

32

M

4

Left V1 & 2

Eye brow & infra orbital

9

27

F

4.5

Right V2

Upper lip

10

48

M

5

Left V2 & 3

Nostril & upper lip

11

39

F

6.5

Left V1 & 2

Nostril & mouth angle

12

51

F

7.5

Right V3

Mentalis

13

39

M

4

Left V3

Mentalis

14

42

F

5.5

Left V2 & 3

Infra orbital & upper lip & mentalis

15

36

M

3.5

Right V2 & 3

Infra orbital & upper lip & mentalis

16

47

F

3

Left V 3

Mentalis

17

55

M

4

Left V2 & 3

Infra orbital & upper lip & mentalis

18

49

F

5

Right V 3

Mentalis

19

56

M

4

Left V2 & 3

Infra orbital & upper lip & mentalis

20

54

F

6

Left V2 & 3

Infra orbital & upper lip & mentalis

  1. M: male, F: female, V1: first division of trigeminal N (ophthalmic), V2: second division of trigeminal N (maxillary), V3: third division of trigeminal nerve (mandibular).